Trial Profile
Evaluation of the effects of duloxetine on norepinephrine transporter inhibition in healthy subjects
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 10 Nov 2021
Price :
$35
*
At a glance
- Drugs Duloxetine (Primary) ; Escitalopram
- Indications Anxiety disorders; Depressive disorders; Fibromyalgia; Pain; Stress incontinence
- Focus Pharmacodynamics
- Sponsors Eli Lilly and Company
- 11 Jun 2007 Status change from recuiting to completed
- 12 Jan 2007 New trial record.